封面
市场调查报告书
商品编码
1514140

全球疼痛管理设备市场

Pain Management Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年,全球疼痛管理设备市场预计将达到 50 亿美元

全球疼痛管理设备市场预计 2023 年将达到 30 亿美元,预计到 2030 年将达到 50 亿美元,2023-2030 年分析期间复合年增长率为 7.7%。神经刺激设备是本报告分析的细分市场之一,预计复合年增长率为 8.3%,到分析期结束时将达到 35 亿美元。分析期内输液帮浦产业的复合年增长率预计为 6.5%。

美国市场预估为7.733亿美元,中国预期复合年增长率为11.6%

预计 2023 年美国疼痛管理设备市场规模将达 7.733 亿美元。中国作为世界第二大经济体,预计到 2030 年市场规模将达到 12 亿美元,2023-2030 年分析期间复合年增长率为 11.6%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 3.7% 和 6.9%。在欧洲,德国的复合年增长率预计为 4.6%。

全球疼痛管理设备市场—主要趋势和驱动因素总结

疼痛管理设备正在成为解决慢性疼痛的重要组成部分,慢性疼痛是一种复杂且持久的疾病,对传统医疗方法提出了挑战。从脊髓刺激设备和鞘内泵等侵入性植入到 TENS 装置和行动应用程式等非侵入性工具,这些设备为安全且不成瘾的治疗开闢了新途径。这些技术特别有利于疼痛管理,例如慢性手术后腰痛,还可以透过直接靶向疼痛受体或改变疼痛信号途径来显着减少对药物的需求。週边神经刺激等创新和虚拟实境等非侵入性技术进一步使治疗领域多样化,既可以缓解疼痛,又不会产生传统疼痛管理方法常见的全身性副作用。

由于几个提高其采用率和有效性的关键因素,疼痛管理设备市场正在扩大。设备技术的进步不断进一步完善这些工具的功能和易用性,整合无线连接和智慧型手机整合等尖端功能。这些技术进步与人们日益认识到慢性疼痛是一个重要的公共卫生问题以及对创新和有效管理策略的需求不断增长相一致。此外,世界人口老化和持续的鸦片危机凸显了需要替代疗法来解决疼痛而又避免成瘾风险,从而推动设备成为首选。这些因素,加上监管政策和保险覆盖范围的扩大,推动了疼痛管理设备的取得和依赖。

由于对有效、安全和以患者为中心的治疗方法的需求,疼痛管理设备的未来看起来充满希望。随着慢性疼痛盛行率的增加,开发提供精确和个人化疼痛缓解的先进技术的重要性也随之增加。持续的技术创新预计将推动数位工具的集成,以提高患者的参与度和治疗依从性。然而,这些设备的有效性必须得到严格的临床研究的支持,以区分真正的治疗效果和安慰剂效果。疼痛管理设备的不断发展不仅反映了技术的进步,而且反映了对疼痛生理学的更深入理解,旨在提供更有针对性和更有效的治疗。随着技术和以患者为中心的策略走在改变现代医疗保健中慢性疼痛管理方式的最前沿,这一领域将大大扩展。

受访企业举例(共34家)

  • Baxter International, Inc.
  • Bio-Medical Research(BMR)Ltd.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-8301

Global Pain Management Devices Market to Reach US$5.0 Billion by 2030

The global market for Pain Management Devices estimated at US$3.0 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Infusion Pumps segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$773.3 Million While China is Forecast to Grow at 11.6% CAGR

The Pain Management Devices market in the U.S. is estimated at US$773.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Pain Management Devices Market - Key Trends and Drivers Summarized

Pain management devices are emerging as a pivotal element in addressing chronic pain, a complex and persistent condition that challenges traditional healthcare approaches. These devices, ranging from invasive implants like spinal cord stimulators and intrathecal pumps to noninvasive tools such as TENS units and mobile applications, offer new avenues for treatment, combining safety with non-addictive properties. Particularly beneficial in managing conditions like chronic back pain post-surgery, these technologies also significantly reduce the need for pharmaceuticals by directly targeting pain receptors or altering pain signal pathways. Innovations such as peripheral nerve stimulation and noninvasive techniques like virtual reality further diversify the treatment landscape, providing relief without the systemic side effects often associated with traditional pain management methods.

The market for pain management devices is expanding, driven by several key factors that enhance their adoption and effectiveness. Advances in device technology continue to refine the functionality and user-friendliness of these tools, integrating cutting-edge features like wireless connectivity and smartphone integration. This technological progression is paralleled by increasing recognition of chronic pain as a significant public health issue, which has elevated demand for innovative and effective management strategies. Furthermore, the aging global population and the ongoing opioid crisis underscore the need for alternative therapies that address pain without the risk of addiction, promoting devices as preferable options. These elements, combined with supportive regulatory policies and broader insurance coverage, facilitate greater access to and reliance on pain management devices.

The future of pain management devices looks promising, fueled by the necessity for effective, safe, and patient-centered treatment modalities. As the prevalence of chronic pain rises, so does the importance of developing advanced technologies that offer precise and personalized pain relief. Continued innovation is expected to drive the integration of digital tools that enhance patient engagement and treatment compliance. However, the effectiveness of these devices must be underpinned by rigorous clinical research to differentiate true therapeutic benefits from placebo effects. The ongoing evolution of pain management devices not only reflects advancements in technology but also a deeper understanding of pain physiology, aiming to provide more targeted and effective treatments. This field is set to expand significantly, with technology and patient-centric strategies at the forefront of transforming how chronic pain is managed in contemporary healthcare.

Select Competitors (Total 34 Featured) -

  • Baxter International, Inc.
  • Bio-Medical Research (BMR) Ltd.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pain Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Market for Home Healthcare Devices Provides the Foundation for Growth
    • Increasing Prevalence of Chronic Pain Conditions Drives Market Growth
    • Technological Innovations in Pain Management Devices Propel Demand
    • Rising Geriatric Population Expands Addressable Market Opportunity
    • Non-invasive Pain Relief Solutions Strengthen Business Case
    • Integration of Wearable Technology in Pain Management Generates Demand
    • Advancements in Neurostimulation Devices Accelerate Market Growth
    • Rise in Sports Injuries and Accidents Drives Adoption of Pain Management Devices
    • Increasing Awareness of Pain Management Solutions. This is How it Impacts the Market
    • E-commerce Platforms Expand Market Reach
    • Personalized Pain Management Devices Spur Customized Healthcare Solutions
    • Development of Portable and User-friendly Devices Strengthens Market Demand
    • Rise in Post-surgical Pain Management Needs Accelerates Market Growth
    • Focus on Improving Patient Quality of Life Drives Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pain Management Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pain Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neuropathic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neuropathic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neuropathic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cancer Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Facial Pain & Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Facial Pain & Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Facial Pain & Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Musculoskeletal Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Musculoskeletal Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Musculoskeletal Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pain Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pain Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pain Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pain Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION